Sildenafil Citrate Tablet
Product Images NDC 80425-0503

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 80425-0503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil 100mg #6 (Sildenafil 100mg 80425 0503 01)

Description: This is a packaging label for Sildenafil 100mg tablets, a generic version of Viagra. The tablets are packed in a quantity of 6, with a lot number and expiration date provided. The medication is manufactured by NIVAGEN PHARMACEUTICALS and should be stored at a temperature between 20-35°C.*

FDA Label Image

Sildenafil 100mg #12 (Sildenafil 100mg 80425 0503 02)

This is a description of Sildenafil 100mg tablets, packed in a box containing 12 tablets. The tablets can be compared to Viagra and have the NDC numbers 80425-0503-02 and 75834-0241-01. The lot number is X000, and the expiration date is 12/31/2026. The manufacturer is NIVAGEN PHARMAC.*

FDA Label Image

Sildenafil 100mg #30 (Sildenafil 100mg 80425 0503 03)

This text appears to be a scan of a medication package for Sildenafil 100mg tablets. The package includes information on the quantity (#30 tablets), comparison to Viagra, NDC numbers, lot number, expiration date, manufacturer details, and the source NDC. It is advised to refer to the original packaging for complete details and instructions.*

FDA Label Image

Sildenafil-citrate-figure-1 (Sildenafil Citrate Figure 1)

FDA Label Image

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)

This text shows numerical values related to blood pressure changes over time. It includes figures and descriptions of the mean standing systolic blood pressure change from the baseline measurement. These values can be used to monitor and assess blood pressure variations in a clinical or research setting.*

FDA Label Image

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)

This text provides data related to a study comparing the effects of Doxazosin, Sildesatil, and Placebo on systolic blood pressure. The figure displays the mean standing systolic blood pressure change from baseline over a period of time. It includes numerical values at specific time points for the different treatments being evaluated.*

FDA Label Image

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)

This text appears to provide information about a study or research involving the drug Doxazosin and its effects on standing systolic blood pressure. The figure labeled as "Figure 4" likely shows the mean change in standing systolic blood pressure from baseline. The dosage of Doxazosin mentioned is possibly 100 ng.*

FDA Label Image

Sildenafil-citrate-figure-5 (Sildenafil Citrate Figure 5)

FDA Label Image

Sildenafil-citrate-figure-6 (Sildenafil Citrate Figure 6)

FDA Label Image

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)

FDA Label Image

Sildenafil-citrate-structure (Sildenafil Citrate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.